Husebye Eystein S, Varhaug Jan Erik, Heimdal Ketil
Endokrinologisk seksjon, Medisinsk avdeling, Haukeland Universitetssjukehus, 5021 Bergen.
Tidsskr Nor Laegeforen. 2005 Nov 3;125(21):2964-7.
The paper reviews inheritable endocrine tumour syndromes based on recent literature and the experience of the authors.
A number of inheritable endocrine tumour syndromes are caused by mutations in proto-oncogenes or tumour suppressor genes. These include multiple endocrine neoplasia (MEN), familial non-MEN neoplasia, Von Hippel-Lindau's disease and familial medullary thyroid carcinoma, pheochromocytoma and paraganglioma. These conditions are rare, but since inheritance is dominant with a near-complete penetrance, a number of carriers with a high risk of developing tumours are regularly found in the families of affected individuals. Identification of carriers with a high risk of developing tumours gives the opportunity to cure disease manifestations at an early stage and to avoid life-threatening complications. Family members who are not carriers can be excluded from follow up. DNA analyses of the most common disease genes are now performed in genetic laboratories in Norway.
本文基于近期文献及作者的经验,对遗传性内分泌肿瘤综合征进行综述。
多种遗传性内分泌肿瘤综合征由原癌基因或肿瘤抑制基因突变引起。这些综合征包括多发性内分泌腺瘤病(MEN)、家族性非MEN肿瘤、冯·希佩尔-林道病、家族性甲状腺髓样癌、嗜铬细胞瘤和副神经节瘤。这些病症较为罕见,但由于遗传方式为显性且几乎完全外显,在受影响个体的家族中经常能发现一些有高肿瘤发生风险的携带者。识别出有高肿瘤发生风险的携带者,可为早期治愈疾病表现及避免危及生命的并发症提供机会。非携带者家庭成员可免于随访。挪威的基因实验室目前正在对最常见疾病基因进行DNA分析。